Hilary Evans-Newton

Hilary Evans-Newton is the chief executive of Alzheimer's Research UK and has been vocal about the implications of the NHS's decision to reject new Alzheimer's drugs, calling it painful and highlighting that patients will miss out on vital innovations due to systemic failures rather than scientific shortcomings.